First Lien Leverage Ratio. On the last day of any Test Period ending on or after the Amendment No. 8 Effective Date on which the Revolving Facility Test Condition is then satisfied, the Parent Borrower shall not permit the First Lien Leverage Ratio to be greater than 6.00:1.00.
Appears in 3 contracts
Samples: Lease I Agreement (Bowlero Corp.), Lease I Agreement (Bowlero Corp.), Lease I Agreement (Bowlero Corp.)
First Lien Leverage Ratio. On the last day of any Test Period ending on or after the Amendment No. 8 Effective last day of the first full Fiscal Quarter ending after the Closing Date on which the Revolving Facility Test Condition is then satisfied, the Parent Borrower shall not permit the First Lien Leverage Ratio to be greater than 6.00:1.006.25:1.00, stepping-down to a First Lien Leverage Ratio of 6.00:1.00 for the Fiscal Quarter ended on or about September 30, 2020 and thereafter.
Appears in 3 contracts
Samples: First Lien Credit Agreement (Isos Acquisition Corp.), First Lien Credit Agreement (Isos Acquisition Corp.), First Lien Credit Agreement (Isos Acquisition Corp.)
First Lien Leverage Ratio. On the last day of any Test Period ending on or after the Amendment No. 8 Effective last day of the second full Fiscal Quarter ending after the Closing Date on which the Revolving Facility Test Condition is then satisfied, the Parent Borrower shall not permit the First Lien Leverage Ratio to be greater than 6.00:1.009.10:1.00.
Appears in 2 contracts
Samples: First Lien Credit Agreement (Ranpak Holdings Corp.), First Lien Credit Agreement (Ranpak Holdings Corp.)
First Lien Leverage Ratio. On the last day of any Test Period ending on or after the Amendment No. 8 Effective Date on which last day of the Revolving Facility Test Condition is then satisfiedfirst full Fiscal Quarter ending after the Closing Date, the Parent Borrower shall not permit the First Lien Leverage Ratio to be greater than 6.00:1.004.00:1.00.
Appears in 2 contracts
Samples: Credit and Guaranty Agreement (Bausch Health Companies Inc.), Restatement Agreement (Valeant Pharmaceuticals International, Inc.)
First Lien Leverage Ratio. On the last day of any Test Period commencing with the last day of the first full Fiscal Quarter ending on or after the Amendment No. 8 Effective Closing Date on which the Revolving Facility Test Condition is then satisfied, the Parent Borrower Company shall not permit the First Lien Leverage Ratio to be greater than 6.00:1.006.30:1.00.
Appears in 1 contract
First Lien Leverage Ratio. On the last day of any Test Period commencing with the last day of the first full Fiscal Quarter ending on or after the Amendment No. 8 Effective Closing Date on which the Revolving Facility Test Condition is then satisfied, the Parent Borrower shall not permit the First Lien Leverage Ratio to be greater than 6.00:1.00[ ]:1.00.
Appears in 1 contract
First Lien Leverage Ratio. On the last day of any Test Period ending on or after the Amendment No. 8 Effective last day of the first full Fiscal Quarter ending after the Closing Date on which the Revolving Facility Test Condition is then satisfied, the Parent Borrower shall not permit the First Lien Leverage Ratio to be greater than 6.00:1.00.6.25:1.00, stepping-down to a First Lien Leverage Ratio of 6.00:1.00 for the Fiscal Quarter ended on or about September 30, 2020 and thereafter. 177
Appears in 1 contract
First Lien Leverage Ratio. On the last day of any Test Period commencing with the last day of the first full Fiscal Quarter ending on or after the Amendment No. 8 Effective Closing Date on which the Revolving Facility Test Condition is then satisfied, the Parent Borrower shall not permit the First Lien Leverage Ratio to be greater than 6.00:1.005.75:1.00.
Appears in 1 contract
